• Tuesday, May 28, 2024
businessday logo


Covid-19: FG to establish indigenous vaccine production company

Patent waiver seen stalling vaccine production in Nigeria

The Federal Government on Tuesday announced plans to set up a vaccine production company in Nigeria and work towards licensed indigenous production of Covid-19 vaccines.

Minister of health, Osagie Ehanire who said this at the PTF briefing in Abuja, informed that the ministry of health was preparing to sign a memorandum of understanding with a first-line pharmaceutical company in Nigeria, on a public-private partnership (PPP) to set up the company, just as he urged Nigerians to avoid non-essential international travels.

The minister also said the government was working with the World Health Organisation (WHO) to ensure Nigeria’s access to the Covid-19 vaccine as soon as it becomes available.

He further expressed concern over the decline in testing in many states of the federation, as over 2.8 million cases were reported globally over the last week.

READ ALSO: Makinde sends amendment bill to lawmakers

According to Ehanire, records show that only Lagos and the FCT have met the testing target of at least one percent of the population. Plateau, Rivers and Gombe have reached over 50 percent of the target, while 25 states were yet to reach 25 percent of their population.

“The evolving global situation of Covid-19 gives us much reason for concern, with half of the cases in Europe. The UK, France, Germany, Spain and others in Europe have resorted to lockdown and other measures, to control the pandemic. With the high volume of air traffic between Nigeria and Europe, we are examining the associated risk factors for Nigeria.

“Our concern is heightened by several emerging factors that challenge whatever gains we may have made in recent months: the inevitable need to reopen air travel, to stimulate economic activities, the imminent reopening of schools and youth service, again necessary for the restoration of social order, but which global experience links with spikes in Covid-19 infection rates in most countries”, the minister said.

He added that the effect of the recent social agitation and unrest, with attendant disruption of services and widespread breach of all infection prevention protocols, the growing lackadaisical attitude to Covid-19 and disregard for safety and simple infection prevention and control measures was also a source of concern.

Ehanire also noted that contact tracing and case finding have declined in states with a consequent reduction in the number of persons tested.

“I, therefore, renew my call on states and stakeholders to step up testing capacity, to help identify positive cases for Isolation or treatment and protect the rest of the population, which is the duty of government. I wish to particularly emphasise the need to protect the elderly and vulnerable, who are the most affected in fatalities”, he said.

He informed that the ministry of health would next week launch an advocacy campaign in which a representative of the minister of health will visit hotspot states that require encouragement, to discuss their specific needs and challenges and find ways of stepping up sample collection for testing.

“I have also directed the Department of Hospital Services to work with NCDC to design criteria and a strategy for sentinel surveillance with sample collection at out-patient units in federal health institutions and their outreaches, to augment the work of state authorities. This should improve the test volume considerably,” the minister said.

And following the resurgence of Covid-19 cases in other countries especially Europe, the minister urged Nigerians to avoid non-essential travels, especially to high burden countries.

He, however, disclosed that 18 travellers out of over 78,000 arrivals, were found to be Covid-19 positive at the second testing in Nigeria.

The minister further informed that an appraisal of Nigeria’s position in the global Covid-19 space has been prepared by the ministerial expert advisory committee on Covid-19 and will be discussed at PTF, before release to the public.